Trusted by the world’s leading institutions
Researchers at the University of Saskatchewan's Vaccine and Infectious Disease Organization (VIDO) have developed a vaccine candidate for hepatitis C, leading to hope in the fight against a disease for which no vaccines are yet available.
Researchers sought to clarify how and what types of cells can be mobilized to aid the heart in repairing itself after a heart attack. What they found surprised them.
An international research team has discovered a signaling pathway in the brain involved in drug addiction, together with a method for blocking its action, that may point to a single treatment strategy for most addictions.
A Canadian team of researchers has discovered a natural defence mechanism that the body deploys to combat nerve cell degeneration observed in persons with Alzheimer's disease (AD).
1) Improving healthcare for newborns; 2) Reducing workplace injury; 3) Shaping community action plans for early childhood development; 4) Helping Canada's minority communities cope with the Tsunami disaster: these and other Canadian stories found in two casebooks launched today by CIHR.
A team led by a Canadian researcher has discovered a process by which a small protein acts directly within muscles to increase the body's metabolism to burn fat while simultaneously suppressing appetite. These findings suggest that the protein, known as the ciliary neurotrophic factor (CNTF), could play a key role as a weight loss agent.
Researchers funded by the Canadian Institutes of Health Research (CIHR) and the Canadian Diabetes Association (CDA) have identified an unsuspected role of a protein named SHP-1 that could constitute a new therapeutic path against Type 2 Diabetes.
A team of researchers have announced an important breakthrough in fighting the human immunodeficiency virus (HIV). For the first time, scientists have identified a defect in the immune response to HIV and found a way to correct the flaw. Dr. Rafick-Pierre Sékaly has confirmed the identification of a new therapeutic target (the PD-1 protein) that restores the function of the T cells whose role is to eliminate cells infected with the virus.
A Canadian population-based cohort study has revealed that medical induction of labour increases the risk of amniotic-fluid embolism. The study was led by Dr. Michael Kramer, Canadian Institutes of Health Research (CIHR) Senior Investigator from McGill University, and will be published in the October 21st issue of The Lancet.
As public health officials around the world keep a nervous eye on the spread of avian influenza, the University of Saskatchewan's Vaccine and Infectious Disease Organization (VIDO) has uncovered a key step in how the influenza virus causes infection.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right